BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 15523688)

  • 1. SEREX identification of new tumor antigens linked to melanoma-associated retinopathy.
    Hartmann TB; Bazhin AV; Schadendorf D; Eichmüller SB
    Int J Cancer; 2005 Mar; 114(1):88-93. PubMed ID: 15523688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitofilin and titin as target antigens in melanoma-associated retinopathy.
    Pföhler C; Preuss KD; Tilgen W; Stark A; Regitz E; Fadle N; Pfreundschuh M
    Int J Cancer; 2007 Feb; 120(4):788-95. PubMed ID: 17131336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer-retina antigens as potential paraneoplastic antigens in melanoma-associated retinopathy.
    Bazhin AV; Dalke C; Willner N; Abschütz O; Wildberger HG; Philippov PP; Dummer R; Graw J; de Angelis MH; Schadendorf D; Umansky V; Eichmüller SB
    Int J Cancer; 2009 Jan; 124(1):140-9. PubMed ID: 18814277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor antigens isolated from a patient with vitiligo and T-cell-infiltrated melanoma.
    Kiniwa Y; Fujita T; Akada M; Ito K; Shofuda T; Suzuki Y; Yamamoto A; Saida T; Kawakami Y
    Cancer Res; 2001 Nov; 61(21):7900-7. PubMed ID: 11691810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SEREX identification of new tumour-associated antigens in cutaneous T-cell lymphoma.
    Hartmann TB; Thiel D; Dummer R; Schadendorf D; Eichmüller S
    Br J Dermatol; 2004 Feb; 150(2):252-8. PubMed ID: 14996095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Melanoma-associated retinopathy: does autoimmunity prolong survival?
    Chan C; O'Day J
    Clin Exp Ophthalmol; 2001 Aug; 29(4):235-8. PubMed ID: 11545422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Humoral immune response against melanoma antigens induced by vaccination with cytokine gene-modified autologous tumor cells.
    Ehlken H; Schadendorf D; Eichmüller S
    Int J Cancer; 2004 Jan; 108(2):307-13. PubMed ID: 14639620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paraneoplastic retinopathy associated with antiretinal bipolar cell antibodies in cutaneous malignant melanoma.
    Weinstein JM; Kelman SE; Bresnick GH; Kornguth SE
    Ophthalmology; 1994 Jul; 101(7):1236-43. PubMed ID: 8035987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression cloning of the cDNA encoding a melanoma-associated Ag recognized by mAb HMB-45. Identification as melanocyte-specific Pmel 17 cDNA.
    Wagner SN; Wagner C; Höfler H; Atkinson MJ; Goos M
    Lab Invest; 1995 Aug; 73(2):229-35. PubMed ID: 7637323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seroreactivity against MAGE-A and LAGE-1 proteins in melanoma patients.
    Usener D; Gerhardt A; Schadendorf D; Eichmüller S
    Br J Dermatol; 2003 Aug; 149(2):282-8. PubMed ID: 12932233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of antiretinal antibodies in melanoma: screening of 77 serum samples from 51 patients with American Joint Committee on Cancer stage I-IV.
    Ladewig G; Reinhold U; Thirkill CE; Kerber A; Tilgen W; Pföhler C
    Br J Dermatol; 2005 May; 152(5):931-8. PubMed ID: 15888149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serological detection of cutaneous T-cell lymphoma-associated antigens.
    Eichmuller S; Usener D; Dummer R; Stein A; Thiel D; Schadendorf D
    Proc Natl Acad Sci U S A; 2001 Jan; 98(2):629-34. PubMed ID: 11149944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serological analysis of human renal cell carcinoma.
    Devitt G; Meyer C; Wiedemann N; Eichmüller S; Kopp-Schneider A; Haferkamp A; Hautmann R; Zöller M
    Int J Cancer; 2006 May; 118(9):2210-9. PubMed ID: 16331622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Melanoma-associated retinopathy: a paraneoplastic autoimmune complication.
    Lu Y; Jia L; He S; Hurley MC; Leys MJ; Jayasundera T; Heckenlively JR
    Arch Ophthalmol; 2009 Dec; 127(12):1572-80. PubMed ID: 20008709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and immunologic characteristics of melanoma-associated retinopathy syndrome: eleven new cases and a review of 51 previously published cases.
    Keltner JL; Thirkill CE; Yip PT
    J Neuroophthalmol; 2001 Sep; 21(3):173-87. PubMed ID: 11725182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Identification of tumor antigens: strategies and perspectives].
    Jäger D; Zippelius A; Knuth A
    Praxis (Bern 1994); 2004 Sep; 93(39):1584-8. PubMed ID: 15500242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic identification of human melanoma antigens using serial analysis of gene expression (SAGE).
    Matsuzaki Y; Hashimoto S; Fujita T; Suzuki T; Sakurai T; Matsushima K; Kawakami Y
    J Immunother; 2005; 28(1):10-9. PubMed ID: 15614040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of selectively expressed genes and antigens in CTCL.
    Hartmann TB; Mattern E; Wiedemann N; van Doorn R; Willemze R; Niikura T; Hildenbrand R; Schadendorf D; Eichmüller SB
    Exp Dermatol; 2008 Apr; 17(4):324-34. PubMed ID: 17979976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor associated antigen recognition by autologous serum in patients with breast cancer.
    Qian F; Odunsi K; Blatt LM; Scanlan MJ; Mannan M; Shah N; Montgomery J; Haddad F; Taylor M
    Int J Mol Med; 2005 Jan; 15(1):137-44. PubMed ID: 15583840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human melanoma-associated retinopathy (MAR) antibodies alter the retinal ON-response of the monkey ERG in vivo.
    Lei B; Bush RA; Milam AH; Sieving PA
    Invest Ophthalmol Vis Sci; 2000 Jan; 41(1):262-6. PubMed ID: 10634629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.